The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
Open accessAbstract
Antibody targeting of tumor-associated vasculature is a promising therapeutic approach in human cancer; however, a specific cell membrane marker for endothelial cells of tumor vasculature has not been discovered yet. Endoglin (CD105) is a cell-surface glycoprotein most recently identified as an optimal indicator of proliferation of human endothelial cells. The finding that CD105 is over-expressed on vascular endothelium in angiogenetic tissues has prompted several pre-clinical studies designed to get a deeper understanding on the role of CD105 in angiogenesis, and to evaluate the most appropriate clinical setting(s) to utilize CD105 as a therapeutic target. In this review, the foreseeable clinical applications of CD105 in human cancer are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., & Akhurst, R. J. (1995) · Development · doi:10.1242/dev.121.6.1845 · Cited by 1,029
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
Smith, M. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206939 · Cited by 835
Cited by
Smith, R. R., Barile, L., Cho, H. C., Leppo, M. K., Hare, J. M., Messina, E., Giacomello, A., Abraham, M. R., & Marbán, E. (2007) · Circulation · doi:10.1161/circulationaha.106.655209 · Cited by 1,140
Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
Dallas, N. A., Samuel, S., Xia, L., Fan, F., Gray, M. J., Lim, S. J., & Ellis, L. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4478 · Cited by 359
Fekete, N., Gadelorge, M., Fürst, D., Maurer, C., Dausend, J., Fleury-Cappellesso, S., Mailänder, V., Lotfi, R., Ignatius, A., Sensebé, L., et al. (2012) · Cytotherapy · doi:10.3109/14653249.2012.655420 · Cited by 285
Wang, F., Ren, F., Ma, Z., Qu, L., Gourgues, R., Xu, C., Baghdasaryan, A., Li, J., Zadeh, I. E., Los, J. W. N., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01130-3 · Cited by 283
The emerging role of TGF-β superfamily coreceptors in cancer
Bernabeu, C., Lopez-Novoa, J. M., & Quintanilla, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.003 · Cited by 254
Metadata
- Authors
- Fonsatti, E., & Maio, M.
- Venue
- Journal of Translational Medicine
- Published
- 2004-06-11
- Volume
- 2
- Issue
- 1
- Pages
- 18-18
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2149757669
- Cited by
- 164
- References
- 3
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. https://app.cochat.ai/papers/10.1186/1479-5876-2-18
- The paper
- Fonsatti, E., & Maio, M. (2004). Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-2-18
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.